Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
349 EUR | +0.72% | -7.18% | -2.92% |
Apr. 17 | VIRBAC : A healthy start to 2024; outlook re-iterated | |
Apr. 17 | Virbac: sales up by almost 10% in Q1 | CF |
Sales 2023 | 1.25B 1.33B | Sales 2024 * | 1.38B 1.47B | Capitalization | 2.92B 3.12B |
---|---|---|---|---|---|
Net income 2023 | 121M 129M | Net income 2024 * | 139M 149M | EV / Sales 2023 | 2.39 x |
Net cash position 2023 | 52.36M 55.99M | Net Debt 2024 * | 73.54M 78.63M | EV / Sales 2024 * | 2.17 x |
P/E ratio 2023 |
25
x | P/E ratio 2024 * |
21.1
x | Employees | 5,459 |
Yield 2023 |
0.37% | Yield 2024 * |
0.42% | Free-Float | 49.58% |
Latest transcript on Virbac
1 day | +0.72% | ||
1 week | -7.18% | ||
Current month | +0.87% | ||
1 month | +1.31% | ||
3 months | +3.25% | ||
6 months | +29.50% | ||
Current year | -2.92% |
Managers | Title | Age | Since |
---|---|---|---|
Sébastien Huron
CEO | Chief Executive Officer | 54 | 05-12-31 |
Habib Ramdani
DFI | Director of Finance/CFO | 48 | 16-01-31 |
Sophie Favini
COO | Chief Operating Officer | - | 23-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 65 | 10-12-31 | |
Philippe Capron
BRD | Director/Board Member | 64 | 03-12-31 |
Chairman | 59 | 97-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.25% | 1 M€ | -.--% | ||
0.02% | 773 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 349 | +0.72% | 7,198 |
24-04-25 | 346.5 | -3.75% | 5,641 |
24-04-24 | 360 | +0.28% | 1,844 |
24-04-23 | 359 | +0.56% | 6,389 |
24-04-22 | 357 | -5.05% | 5,462 |
Real-time Euronext Paris, April 26, 2024 at 11:35 am EDT
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-2.92% | 3.12B | |
-19.73% | 72.39B | |
-11.01% | 6.54B | |
+15.88% | 3.43B | |
-0.68% | 1.4B | |
-17.27% | 1.34B | |
-2.73% | 1.26B | |
-14.67% | 1.12B | |
-5.37% | 990M | |
-24.06% | 805M |
- Stock Market
- Equities
- VIRP Stock